Cardiogenic shock in acute myocardial infarction

Catheterization and Cardiovascular Interventions

Volumn 59, Issue 1, 2003, Pages 34-43

  Ashby, Dale T ^a,b   Stone, Gregg W ^a   Moses, Jeffrey W ^a  

^a Lenox Hill Heart/Vascular Institute   (United States)

^b CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT; DOBUTAMINE; DOPAMINE; GLYCERYL TRINITRATE; INOTROPIC AGENT; NORADRENALIN; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; VASODILATOR AGENT;

ACUTE HEART INFARCTION; AORTA BALLOON; CARDIOGENIC SHOCK; FIBRINOLYTIC THERAPY; HEART HEMODYNAMICS; HEART RIGHT VENTRICLE INFARCTION; INCIDENCE; LUNG EDEMA; PATHOPHYSIOLOGY; REVIEW;

HUMANS; INCIDENCE; MYOCARDIAL INFARCTION; RISK FACTORS; SHOCK, CARDIOGENIC;

EID: 0038300470     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.10521     Document Type: Review

References (85)

1. Goldberg RJ, Gore JM, Alpert JS, et al. Cardiogenic shock after acute myocardial infarction: incidence and mortality from a community-wide perspective. 1975-1988. N Engl J Med 1991;325:1117.
2. Braunwald EB. Hemodynamic disturbances in acute myocardial infarction. In: Braunwald EB, editor. Heart disease. Philadelphia: W.B. Saunders; 1997. p 1233-1245.
3. Hochman JS, Boland J, Sleeper LA, Porway M, Brinker J, Col J, et al. Current spectrum of cardiogenic shock and effect of early revascularization on mortality: results of an international registry SHOCK registry investigators. Circulation 1995;91:873-881.
4. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, McKinlay SM, LeJemtel TH. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med 1999;341:625-634.
5. Goldberg RJ, Samad NA, Yarzebski J, Gurwitz J, Bigelow C, Gore JM. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med 1999;340:1162-1168.
6. O'Gara PT. Acute myocardial infarction: primary pump failure. In: Fuster V, Ross R, Topol EJ, editors. Atherosclerosis coronary artery disease. Philadelphia: Lippincott-Raven; 1996. p 1051-1064.
7. Berger PB, Tuttle RH, Holmes DR Jr, Topol EJ, Aylward PE, Horgan JH, Califf RM. One-year survival among patients with acute myocardial infarction complicated by cardiogenic shock, and its relation to early revascularization: results from the GUSTO-I trial. Circulation 1999;99:873-878.
8. Subramanian VA, Roberts AJ, Zema MJ, Abel RM, McCabe JC, Hoover E, Kligfield P, Gay WA Jr. Cardiogenic shock following acute myocardial infarction: late functional results after emergency cardiac surgery. NY State J Med 1980;80:947-952.
9. Scheidt S, Ascheim R, Killip T. Shock after acute myocardial infarction: a clinical and hemodynamic profile. Am J Cardiol 1970;26:556.
10. Holmes DR Jr, Bates ER, Kleiman NS, Sadowski Z, Horgan JH, Morris DC, Califf RM, Berger PB, Topol EJ. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience - the GUSTO-I investigators. J Am Coll Cardiol 1995;26:668-674.
11. Holmes DR Jr, Berger PB, Hochman JS, Granger CB, Thompson TD, Califf RM, Vahanian A, Bates ER, Topol EJ. Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation. Circulation 1999;100:2067-2073.
12. Alonso DR, Scheidt S, Post M, et al. Pathophysiology of cardiogenic shock: quantification of myocardial necrosis, clinical pathologic and electrocardiographic correlation. Circulation 1973;48:588.
13. Califf RM, Bengtson JR. Cardiogenic shock. N Engl J Med 1994;330:1724-1730.
14. Hollenberg SM, Kavinsky CJ, Parrillo JE. Cardiogenic shock. Ann Intern Med 1999;131:47-59.
15. Hands ME, Rutherford JD, Muller JE, Davies G, Stone PH, Parker C, Braunwald E. The in-hospital development of cardiogenic shock after myocardial infarction: incidence, predictors of occurrence, outcome and prognostic factors - the MILIS study group. J Am Coll Cardiol 1989;14:40-46.
16. Hochman JS, Buller CE, Dzavik V. Cardiogenic shock complicating AMI: etiologies, management, and outcome - overall findings of the SHOCK trial registry. Circulation 1998;98(Suppl 1): 1-778.
17. Leor J, Goldbourt U, Reicher-Reiss H, Kaplinsky E, Behar S. Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: incidence, risk factors, and outcome - SPRINT study group. Am J Med 1993;94:265-273.
18. Carnendran L, Abboud R, Sleeper LA, Gurunathan R, Webb JG, Menon V, Dzavik V, Cocke T, Hochman JS. Trends in cardiogenic shock: report from the SHOCK study - the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock? Eur Heart J 2001;22:472-478.
19. Page DL, Caulfield JB, Kastor JA, DeSanctis RW, Sanders CA. Myocardial changes associated with cardiogenic shock. N Engl J Med 1971;285:133-137.
20. Hochman JS, Sleeper LA, White HD, Dzavik V, Wong SC, Menon V, Webb JG, Steingart R, Picard MH, Menegus MA, Boland J, Sanborn T, Buller CE, Modur S, Forman R, DesvigneNickens P, Jacobs AK, Slater JN, LeJemtel TH, SHOCK investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock: one-year survival following early revascularization for cardiogenic shock. JAMA 2001;285:190-192.
21. Herrick JB. Clinical features of sudden obstruction of the coronary arteries. JAMA 1912;39:2015-2020.
22. Nishimura RA, Reeder GS, Miller FA Jr, Ilstrup DM, Shub C, Seward JB, Tajik AJ. Prognostic value of predischarge 2-dimensional echocardiogram after acute myocardial infarction. Am J Cardiol 1984;53:429-432.
23. Holmes DR Jr, Califf RM, Van de Werf F, Berger PB, Bates ER, Simoons ML, White HD, Thompson TD, Topol EJ. Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial. Lancet 1997;349:75-78.
24. Connors AF Jr, Speroff T, Dawson NV, Thomas C, Harrell FE Jr, Wagner D, Desbiens N, Goldman L, Wu AW, Califf RM, Fulkerson WJ Jr, Vidaillet H, Broste S, Bellamy P, Lynn J, Knaus WA. The effectiveness of right heart catheterization in the initial care of critically ill patients: SUPPORT investigators. JAMA 1996;276:889-897.
25. Goldberg LI, Hsieh YY, Resnekov L. Newer catecholamines for treatment of heart failure and shock: an update on dopamine and a first look at dobutamine. Prog Cardiovasc Dis 1977;19:327-340.
26. Richard C, Ricome JL, Rimailho A, Bottineau G, Auzepy P. Combined hemodynamic effects of dopamine and dobutamine in cardiogenic shock. Circulation 1983;67:620-626.
27. Willerson JT, Curry GC, Watson JT, Leshin SJ, Ecker RR, Mullins CB, Platt MR, Sugg WL. Intraaortic balloon counterpulsation in patients in cardiogenic shock, medically refractory left ventricular failure and/or recurrent ventricular tachycardia. Am J Med 1975;58:183-191.
28. Ferguson JJ III, Cohen M, Freedman RJ Jr, Stone GW, Miller MF, Joseph DL, Ohman EM. The current practice of intra-aortic balloon counterpulsation: results from the Benchmark registry. J Am Coll Cardiol 2001;38:1456-1462.
29. Alderman JD, Gabliani GI, McCabe CH, Brewer CC, Lorell BH, Pastemak RC, Skillman JJ, Steer ML, Baim DS. Incidence and management of limb ischemia with percutaneous wire-guided intraaortic balloon catheters. J Am Coll Cardiol 1987;9:524-530.
30. Stomel RJ, Rasak M, Bates ER. Treatment strategies for acute myocardial infarction complicated by cardiogenic shock in a community hospital. Chest 1994;105:997-1002.
31. Kovack PJ, Rasak MA, Bates ER, Ohman EM, Stomel RJ. Thrombolysis plus aortic counterpulsation: improved survival in patients who present to community hospitals with cardiogenic shock. J Am Coll Cardiol 1997;29:1454-1458.
32. Anderson RD, Ohman EM, Holmes DR Jr, Col I, Stebbins AL, Bates ER, Stomel RJ, Granger CB, Topol EJ, Califf RM. Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I study Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. J Am Coll Cardiol 1997;30:708-715.
33. Sanborn TA, Sleeper LA, Bates ER, Jacobs AK, Boland J, French JK, Dens J, Dzavik V, Palmeri ST, Webb JG, Goldberger M, Hochman JS. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK trial registry. J Am Coll Cardiol 2000;36(3 Suppl A):1123-1129.
34. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397-402.
35. Second International Study of Infarct Survival Collaborative Group (ISI-2). Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction. Lancet 1988;2:349-360.
36. GUSTO investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-682.
37. International Study Group. In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomized between altepace and streptokinase with or without heparin. Lancet 1990;336:71-75.
38. Hochman SJS, Gersh BJ. Acute myocardial infarction: Complications. In: Topol EJ, editor. Textbook of cardiovascular medicine. Philadelphia: Lippincott-Raven; 1998. p 437-480.
39. Wilcox RG, von der Lippe G, Olsson CG, Skene AM, Hampton JR. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction: Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet 1988;2:525-530.
40. White HD. Cardiogenic shock: a more aggressive approach is now warranted. Eur Heart J 2000;21:1897-1901.
41. O'Neill W, Erbel R, Laufer N, Walton J, Bates E, Topol E. Coronary angioplasty therapy of cardiogenic shock complicating acute myocardial infarction. Circulation 1985;72(Suppl II):309.
42. Lee L, Bates ER, Pitt B, Walton JA, Laufer N, O'Neill WW. Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock. Circulation 1988;78:1345-1351.
43. Landin RJ, Rothbaum DA, Linnemeier TJ, Ball MW. Hospital mortality of patients undergoing emergency angioplasty for acute myocardial infarction: relationship of mortality to cardiogenic shock and unsuccessful angioplasty. Circulation 1988;78(Suppl II):II9.
44. Verna E, Repetto S, Boscarini M, Ghezzi I, Binaghi G. Emergency coronary angioplasty in patients with severe left ventricular dysfunction or cardiogenic shock after acute myocardial infarction. Eur Heart J 1989;10:958-966.
45. Kaplan AJ, Bengtson JR, Aronson LG, Frid OJ, Phillips HR, Quigley PJ, et al. Reperfusion improves survival in patients with cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol 1990;15:155A.
46. Lee L, Erbel R, Brown TM, Laufer N, Meyer J, O'Neill WW. Multicenter registry of angioplasty therapy of cardiogenic shock: initial and long-term survival. J Am Coll Cardiol 1991;17:599-603.
47. Gacioch GM, Ellis SG, Lee L, Bates ER, Kirsh M, Walton JA, et al. Cardiogenic shock complicating acute myocardial infarction: the use of coronary angioplasty and the integration of the new support devices into patient management. J Am Coll Cardiol 1992;19:647-653.
48. Moosvi AR, Khaja F, Villanueva L, Gheorghiade M, Douthat L, Goldstein S. Early revascularization improves survival in cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol 1992;19:907-914.
49. Laney PL, Dell'Italia LJ, Brooks SR, Harrell RR, Sawyer JA, Hood WP, et al. Follow-up exercise function in patients presenting with cardiogenic shock and acute transmural myocardial infarction. J Am Coll Cardiol 1993;21:77A.
50. Eltchaninoff H, Simpfendorfer C, Franco I, Raymond RE, Casale PN, Whitlow PL. Early and 1-year survival rates in acute myocardial infarction complicated by cardiogenic shock: a retrospective study comparing coronary angioplasty with medical treatment. Am Heart J 1995;130(3 Pt 1):459-464.
51. Antoniucci D, Valenti R, Santoro GM, Bolognese L, Trapani M, Moschi G, et al. Systematic direct angioplasty and stent-supported direct angioplasty therapy for cardiogenic shock complicating acute myocardial infarction: in-hospital and long-term survival. J Am Coll Cardiol 1998;31:294-300.
52. Ajani AE, Maruff P, Warren R, Eccleston D, Dick R, MacIsaac A, Rowe M, Lefkovits J. Impact of early percutaneous coronary intervention on short- and long-term outcomes in patients with cardiogenic shock after acute myocardial infarction. Am J Cardiol 2001;87:633-635.
53. Berger PB, Holmes DR Jr, Stebbins AL, Bates ER, Califf RM, Topol EJ. Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-1) trial: an observational study. Circulation 1997;96:122-127.
54. Grines CL, Cox DA, Stone GW, Garcia E, Mattos LA, Giambartolomei A, Brodie PR, Madonna O, Eijgelshoven M, Landsky AJ, O'Neill WW, Morice MC. Coronary angioplasty with or without stent implantation for acute myocardial infarction. N Engl J Med 1999;341:1949-1956.
55. Stone GW, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Carroll JD, Rutherford BD, Lansky AJ, the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) investigators. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 2002;346:957-966.
56. Schultz RD, Heuser RR, Hatler C, Frey D. Use of c7E3 Fab in conjunction with primary coronary stenting for acute myocardial infarctions complicated by cardiogenic shock. Cathet Cardiovasc Diagn 1996;39:143-148.
57. Giri S, Mitchel J, Azar RR, Kiernan FJ, Fram DB, McKay RG, Mennett R, Clive J, Hirst JA. Results of primary percutaneous transluminal coronary angioplasty plus abciximab with or without stenting for acute myocardial infarction complicated by cardiogenic shock. Am J Cardiol 2002;89:126-131.
58. Chan AW, Chew DP, Bhatt DL, Moliterno DJ, Topol EJ, Ellis SG. Long-term mortality benefit with the combination of stents and abciximab for cardiogenic shock complicating acute myocardial infarction. Am J Cardiol 2002;89:132-136.
59. Hasdai D, Harrington RA, Hochman JS, Califf RM, Battler A, Box JW, Simoons ML, Deckers J, Topol EJ, Holmes DR Jr. Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation. J Am Coll Cardiol 2000;36:685-692.
60. Dunkman WB, Leinbach RC, Buckley MJ, Mundth ED, Kantrowitz AR, Austen WG, Sanders CA. Clinical and hemodynamic results of intraaortic balloon pumping and surgery for cardiogenic shock. Circulation 1972;46:465-477.
61. Bardet J, Masquet C, Kahn JC, Gourgon R, Bourdarias JP, Mathivat A, Bouvrain Y. Clinical and hemodynamic results of intraortic balloon counterpulsation and surgery for cardiogenic shock. Am Heart J 1977;93:280-288.
62. Laks H, Rosenkranz E, Buckberg GD. Surgical treatment of cardiogenic shock after myocardial infarction. Circulation 1986; 74(5 Pt 2):III11-III16.
63. Urban P, Stauffer JC, Bleed D, Khatchatrian N, Amann W, Bertel O, van den Brand M, Danchin N, Kaufmann U, Meier B, Machecourt J, Pfisterer M. A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction: the (Swiss) Multicenter Trial of Angioplasty for Shock-(S)MASH. Eur Heart J 1999;20:1030-1038.
64. Zehender M, Kasper W, Kauder E, Schonthaler M, Geibel A, Olschewski M, Just H. Right ventricular infarction as an independent predictor of prognosis after acute inferior myocardial infarction. N Engl J Med 1993;328:981-988.
65. Coma-Canella I, Lopez-Sendon J, Gamallo C. Low output syndrome in right ventricular infarction. Am Heart J 1979;98:613-620.
66. Lopez-Sendon J, Coma-Canella I, Gamallo C. Sensitivity and specificity of hemodynamic criteria in the diagnosis of acute right ventricular infarction. Circulation 1981;64:515-525.
67. Dell'Italia LJ, Starling MR, Crawford MH, Boros BL, Chaudhuri TK, O'Rourke RA. Right ventricular infarction: identification by hemodynamic measurements before and after volume loading and correlation with noninvasive techniques. J Am Coll Cardiol 1984;4:931-939.
68. Braat SH, de Zwaan C, Brugada P, Coenegracht JM, Wellens HJJ. Right ventricular involvement with acute inferior wall myocardial infarction identifies high risk of developing atrioventricular nodal conduction disturbances. Am Heart J 1984;107:1183-1187.
69. Kinch JW, Ryan TJ. Right ventricular infarction. N Engl J Med 1994;330:1211-1217.
70. Schuler G, Hofmann M, Schwarz F, et al. Effect of successful thrombolytic therapy on right ventricular function in acute inferior wall myocardial infarction. Am J Cardiol 1984;54:951-957.
71. Moreyra AE, Suh C, Porway MN, Costis JB. Rapid hemodynamic improvement in right ventricular infarction after coronary angioplasty. Chest 1988;94:197-199.
72. Berger PB, Ruocco NA Jr, Ryan TJ, et al. Frequency and significance of right ventricular dysfunction during inferior wall left ventricular myocardial infarction treated with thrombolytic therapy (results from the Thrombolysis in Myocardial Infarction [TIMI] II trial). Am J Cardiol 1993;71:1148-1152.
73. Menon V, Webb JG, Hillis LD, Sleeper LA, Abboud R, Dzavik V, Slater JN, Forman R, Monrad ES, Talley JD, Hochman JS. Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK trial registry. J Am Coll Cardiol 2000;36(3 Suppl A):1110-1116.
74. Slater J, Brown RJ, Antonelli TA, Menon V, Boland J, Col J, Dzavik V, Greenberg M, Menegus M, Connery C, Hochman JS. Cardiogenic shock due to cardiac free-wall rupture or tamponade after acute myocardial infarction: a report from the SHOCK trial registry. J Am Coll Cardiol 2000;36(3 Suppl A):1117-1122.
75. Thompson CR, Buller CE, Sleeper LA, Antonelli TA, Webb JG, Jaber WA, Abel JG, Hochman JS. Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a report from the SHOCK trial registry. J Am Coll Cardiol 2000;36(3 Suppl A):1104-1109.
76. Hale SL, Kloner RA. Myocardial temperature in acute myocardial infarction: protection with mild regional hypothermia. Am J Physiol 1997;273(1 Pt 2):H220-H227.
77. Dae MW, Gao DW, Sessler DI, Chair K, Stillson CA. Effect of endovascular cooling on myocardial temperature, infarct size, and cardiac output in human-sized pigs. Am J Physiol Heart Circ Physiol 2002;282:H1584-H1591.
78. Miki T, Liu GS, Cohen MV, Downey JM. Mild hypothermia reduces infarct size in the beating rabbit heart: a practical intervention for acute myocardial infarction? Basic Res Cardiol 1998;93:372-383.
79. Schwartz DS, Bremner RM, Baker CJ, Uppal KM, Barr ML, Cohen RG, Starnes VA. Regional topical hypothermia of the beating heart: preservation of function and tissue. Ann Thorac Surg 2001;72:804-809.
80. Sterling DL, Thornton JD, Swafford A, Gottlieb SF, Bishop SP, Stanley AW, Downey JM. Hyperbaric oxygen limits infarct size in ischemic rabbit myocardium in vivo. Circulation 1993;88:1931-1936.
81. Spears JR, Henney C, Prcevski P, Xu R, Li L, Brereton GJ, DiCarli M, Spanta A, Crilly R, Sulaiman AM, Hadeed S, Lavine S, Patterson WR, Creech J, Vander Heide R. Aqueous oxygen hyperbaric reperfusion in a porcine model of myocardial infarction. J Invas Cardiol 2002;14:160-166.
82. Stavitsky Y, Shandling AH, Ellestad MH, Hart GB, Van Natta B, Messenger JC, Strauss M, Dekleva MN, Alexander JM, Mattice M, Clarke D. Hyperbaric oxygen and thrombolysis in myocardial infarction: the "HOT MI" randomized multicenter study. Cardiology 1998;90:131-136.
83. Mahaffey KW, Puma JA, Barbagelata NA, DiCarli MF, Leesar MA, Browne KF, Eisenberg PR, Bolli R, Casas AC, MolinaViamonte V, Orlandi C, Blevins R, Gibbons RJ, Califf RM, Granger CB. Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction Study of Adenosine (AMISTAD) trial. J Am Coll Cardiol 1999;34:1711-1720.
84. Champagnac D, Claudel JP, Chevalier P, Desseigne P, Canu G, Chuzel M, Ninet J, Dureau G, Kirkorian G, Lyon L. Primary cardiogenic shock during acute myocardial infarction: results of emergency cardiac transplantation. Eur Heart J 1993;14:925-929.
85. Bowen FW, Carboni AF, O'Hara ML, Pochettino A, Rosengard BR, Morris RJ, Gorman RC, Gorman JH III, Acker MA. Application of "double bridge mechanical" resuscitation for profound cardiogenic shock leading to cardiac transplantation. Ann Thorac Surg 2001;72:86-90.